05/04/2026 | Press release | Distributed by Public on 05/04/2026 08:26
SAN FRANCISCO - May 4, 2026 - Affiliates of The Roxborough Group LLC ("Roxborough") and Paceline Investors, LLC ("Paceline") announce the acquisition of 2581 Junction Avenue, a 102,722-square-foot heavy-power R&D facility on a 5.4-acre site located in San Jose, California, for $29.2 million.
The property, originally constructed in 1983 and subsequently upgraded for advanced manufacturing use, is located in Silicon Valley's North San Jose submarket, an established hub for technology, semiconductor, and advanced manufacturing companies. The single-tenant building is currently leased to Ensurge Micropower, a developer of solid-state battery technology.
2581 Junction features specialized infrastructure, including approximately 8,500 amps of power capacity and existing cleanroom improvements, making it well-suited for a range of advanced manufacturing, hardware, and research and development users. The availability of high-power facilities in Silicon Valley remains limited due to long lead times for new electrical infrastructure, positioning the property favorably relative to similarly sized buildings within the market.
"The acquisition of 2581 Junction aligns with Roxborough's strategy of targeting assets with differentiated infrastructure in supply-constrained markets with strong underlying demand," said Matt Yamodim, Vice President of Commercial Acquisitions at Roxborough. "Roxborough is excited to partner with Paceline to acquire an asset in a location that consistently attracts strong, high-quality tenants in a market that is seeing an influx of demand by companies in the hardware and manufacturing space. The property's size, existing power capacity, and location make it a highly functional facility for a broad range of users in this market."
"We are attracted to the building's functional qualities and its existing electrical power infrastructure, which is rare for a building of this size in the Silicon Valley market," said Jay Atkinson, Founder & Managing Principal at Paceline Investors. "We plan to enhance these valuable attributes with additional investment to elevate its competitive position in the market. We are pleased to expand our valued relationship with the Roxborough Group with this investment."
2581 Junction marks Roxborough's first R&D investment in Silicon Valley for Roxborough Fund III, L.P., a $518 million discretionary fund focused on opportunistic and value-add investments.
About Paceline InvestorsPaceline Investors is a privately-owned commercial real estate investor headquartered in San Francisco, California and focuses its energies on investing in the Bay Area where we live and call home. It seeks languishing, under-appreciated properties that require an active business plan that synergizes a combination of physical renovation, building system upgrades and leasing to tenants seeking a new, upgraded commercial home. Paceline invests alongside our financial partners (debt and equity) and communicates with them openly and transparently. https://www.pacelineinvestors.com
About The Roxborough Group, LLCThe Roxborough Group, LLC ("Roxborough") is a San Francisco-based real estate private equity firm focused on unlocking value from investments targeting dynamic markets with durable economic drivers and strong demographic tailwinds. As a trusted capital partner with a flexible mandate, Roxborough employs a disciplined, thematic, research-driven investment approach that integrates macroeconomic trends, asset-level fundamentals, and event-driven dislocations to identify compelling opportunities on a risk-adjusted basis. Roxborough invests both directly and through partnerships with experienced operators, pursuing a range of value-add, opportunistic, and longer-duration strategies. For more information, please visit https://www.theroxboroughgroup.com.